News

NUS researchers tap AI to improve effectiveness of Covid-19 drugs

Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings.

Read more: https://news.nus.edu.sg/nus-researchers-tap-on-ai-to-improve-effectiveness-of-covid-19-drugs/

view MORE related

News

2024
AI will have to proof itself to gain greater traction in healthcare sector, say industry player
More Details >
2024
For intermittent fasters, 4 protein-rich meals can help you stay full and energized on the go
More Details >
2024
Harnessing AI to see a patient’s unique patterns
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg

The Institute for Digital Medicine (WisDM)

  • 28 Medical Drive, #05-COR,
    Singapore 117456

© National University of Singapore. All Rights Reserved.